Today is 2019-12-08

Dedifferentiated liposarcoma with an unusual presentation of disseminated intraperitoneal sarcomatosis: A diagnostic conundrum
download

注册号:

Registration number:

ChiCTR1900023494 

最近更新日期:

Date of Last Refreshed on:

2019-05-31 

注册时间:

Date of Registration:

2019-05-31 

注册号状态:

补注册  

Registration Status:

Retrospective registration  

注册题目:

Dedifferentiated liposarcoma with an unusual presentation of disseminated intraperitoneal sarcomatosis: A diagnostic conundrum 

Public title:

Dedifferentiated liposarcoma with an unusual presentation of disseminated intraperitoneal sarcomatosis: A diagnostic conundrum 

注册题目简写:

 

English Acronym:

 

研究课题的正式科学名称:

Dedifferentiated liposarcoma with an unusual presentation of disseminated intraperitoneal sarcomatosis: A diagnostic conundrum 

Scientific title:

Dedifferentiated liposarcoma with an unusual presentation of disseminated intraperitoneal sarcomatosis: A diagnostic conundrum 

研究课题代号(代码):

Study subject ID:

 

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

 

申请注册联系人:

Cai Mingzhe 

研究负责人:

Cai Mingzhe 

Applicant:

Cai Mingzhe 

Study leader:

Cai Mingzhe 

申请注册联系人电话:

Applicant telephone:

+65 92969308 

研究负责人电话:

Study leader's telephone:

+65 92969308 

申请注册联系人传真 :

Applicant Fax:

 

研究负责人传真:

Study leader's fax:

 

申请注册联系人电子邮件:

Applicant E-mail:

mingzhe.cai@u.nus.edu 

研究负责人电子邮件:

Study leader's E-mail:

mingzhe.cai@u.nus.edu 

申请单位网址(自愿提供):

Applicant website(voluntary supply):

 

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

 

申请注册联系人通讯地址:

新加坡学院路20号 

研究负责人通讯地址:

新加坡学院路20号 

Applicant address:

20 College Road, Singapore 169856 

Study leader's address:

20 College Road, Singapore 169856 

申请注册联系人邮政编码:

Applicant postcode:

 

研究负责人邮政编码:

Study leader's postcode:

 

申请人所在单位:

新加坡总医院 

Applicant's institution:

Singapore General Hospital 

是否获伦理委员会批准:

否 

Approved by ethic committee:

NO 

伦理委员会批件文号:

Approved No. of ethic committee:

 

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

 

Name of the ethic committee:

 

伦理委员会批准日期:

Date of approved by ethic committee:

2013-08-26 

伦理委员会联系人:

 

Contact Name of the ethic committee:

 

伦理委员会联系地址:

 

Contact Address of the ethic committee:

 

伦理委员会联系人电话:

Contact phone of the ethic committee:

 

伦理委员会联系人邮箱:

Contact email of the ethic committee:

 

研究实施负责(组长)单位:

Nil 

Primary sponsor:

NIL 

研究实施负责(组长)单位地址:

Nil 

Primary sponsor's address:

NIL 

试验主办单位(项目批准或申办者):

Secondary sponsor:

经费或物资来源:

Nil 

Source(s) of funding:

NIL 

研究疾病:

Sarcoma 

Target disease:

Sarcoma 

研究疾病代码:

 

Target disease code:

 

研究类型:

观察性研究 

Study type:

Observational study 

研究所处阶段:

回顾性研究 

Study phase:

Retrospective study 

研究目的:

This is a case report describing a case of dedifferentiated liposarcoma with an atypical primary presentation of disseminated intraperitoneal sarcomatosis. 

Objectives of Study:

This is a case report describing a case of dedifferentiated liposarcoma with an atypical primary presentation of disseminated intraperitoneal sarcomatosis. 

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

研究设计:

病例研究 

Study design:

Case study 

纳入标准:

Nil 

Inclusion criteria

NIL 

排除标准:

Nil 

Exclusion criteria:

NIL 

研究实施时间:

Study execute time:

From2018-11-01To 2018-12-31 

干预措施:

Interventions:

组别:

Case

样本量:

1

Group:

Case

Sample size:

干预措施:

干预措施代码:

Intervention:

NIL

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

新加坡 

省(直辖市):

 

市(区县):

 

Country:

Singapore 

Province:

 

City:

 

单位(医院):

新加坡总医院 

单位级别:

三级医院 

Institution
hospital:

Singapore General Hospital  

Level of the institution:

Tertiary 

测量指标:

Outcomes:

指标中文名:

Nil

指标类型:

主要指标 

Outcome:

NIL

Type:

Primary indicator 

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NIL

Tissue:

NIL

人体标本去向

其它 

说明

Fate of sample:

Others 

Note:

NIL

征募研究对象情况:

Recruiting status:

结束

Completed

年龄范围:

Participant age:

最小 Min age 0 years
最大 Max age 100 years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

Nil

Randomization Procedure (please state who generates the random number sequence and by what method):

NIL

盲法:

N/A

Blinding:

N/A

原始数据公开时间:

The time of sharing IPD:

Real time access

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

Not stated

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Not stated

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Nil

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

NIL

数据管理委员会:

Data Managemen Committee:

无/No

注册人:

Name of Registration:

 2019-05-31
return list